Menstrual Phase Affects Coagulation and Hematological Parameters during Central Hypovolemia

Background: It has been reported that women have a higher number of heart attacks in the “follicular phase” of the menstrual cycle. We, therefore, tested the hypothesis that women in the follicular phase exhibit higher coagulability. As lower body negative pressure (LBNP) has been used previously to...

Full description

Bibliographic Details
Main Authors: Nandu Goswami, Bianca Brix, Andreas Roessler, Martin Koestenberger, Gilbert Reibnegger, Gerhard Cvirn
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/10/3118
_version_ 1797552493941489664
author Nandu Goswami
Bianca Brix
Andreas Roessler
Martin Koestenberger
Gilbert Reibnegger
Gerhard Cvirn
author_facet Nandu Goswami
Bianca Brix
Andreas Roessler
Martin Koestenberger
Gilbert Reibnegger
Gerhard Cvirn
author_sort Nandu Goswami
collection DOAJ
description Background: It has been reported that women have a higher number of heart attacks in the “follicular phase” of the menstrual cycle. We, therefore, tested the hypothesis that women in the follicular phase exhibit higher coagulability. As lower body negative pressure (LBNP) has been used previously to assess coagulation changes in whole blood (WB) samples in men and women, effects of menstrual phase on coagulation was assessed during LBNP. Methods: Seven women, all healthy young participants, with no histories of thrombotic disorders and not on medications, were tested in two phases of the menstrual cycle (early follicular (EF) and mid-luteal (ML)). LBNP was commenced at −10 mmHg and increased by −10 mmHg every 5 min until a maximum of −40 mmHg. Recovery up to 10 min was also monitored. Blood samples were collected at baseline, at end of LBNP, and at end of recovery. Hemostatic profiling included comparing the effects of LBNP on coagulation values in both phases of the menstrual cycle using standard coagulation tests, calibrated automated thrombogram, thrombelastometry, impedance aggregometry, and markers of thrombin formation. Results: LBNP led to coagulation activation determined in both plasma and WB samples. During both phases, coagulation was affected during LBNP, as reflected in their decreased partial thromboplastin time (PTT) and elevated coagulation factor VIII FVIII, F1 + 2, and thrombin-antithrombin (TAT) levels. Additionally, during the ML phase, greater PT [%] and shorter time to peak (ttPeak) values (implying faster maximum thrombin formation) suggest that women in the ML phase are relatively hypercoagulable compared to the early follicular phase. Conclusions: These results suggest that thrombosis occurs more during the midluteal phase, a finding with substantial medical implications.
first_indexed 2024-03-10T16:00:54Z
format Article
id doaj.art-8d25f3fdae7f4e2e9317e6824f421299
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T16:00:54Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-8d25f3fdae7f4e2e9317e6824f4212992023-11-20T15:15:29ZengMDPI AGJournal of Clinical Medicine2077-03832020-09-01910311810.3390/jcm9103118Menstrual Phase Affects Coagulation and Hematological Parameters during Central HypovolemiaNandu Goswami0Bianca Brix1Andreas Roessler2Martin Koestenberger3Gilbert Reibnegger4Gerhard Cvirn5Physiology Division, Otto Loewi Research Center, Medical University of Graz, 8036 Graz, AustriaPhysiology Division, Otto Loewi Research Center, Medical University of Graz, 8036 Graz, AustriaPhysiology Division, Otto Loewi Research Center, Medical University of Graz, 8036 Graz, AustriaDepartment of Pediatric Cardiology, Medical University of Graz, 8036 Graz, AustriaPhysiological Chemistry Division, Otto Loewi Research Center, Medical University of Graz, 8036 Graz, AustriaPhysiological Chemistry Division, Otto Loewi Research Center, Medical University of Graz, 8036 Graz, AustriaBackground: It has been reported that women have a higher number of heart attacks in the “follicular phase” of the menstrual cycle. We, therefore, tested the hypothesis that women in the follicular phase exhibit higher coagulability. As lower body negative pressure (LBNP) has been used previously to assess coagulation changes in whole blood (WB) samples in men and women, effects of menstrual phase on coagulation was assessed during LBNP. Methods: Seven women, all healthy young participants, with no histories of thrombotic disorders and not on medications, were tested in two phases of the menstrual cycle (early follicular (EF) and mid-luteal (ML)). LBNP was commenced at −10 mmHg and increased by −10 mmHg every 5 min until a maximum of −40 mmHg. Recovery up to 10 min was also monitored. Blood samples were collected at baseline, at end of LBNP, and at end of recovery. Hemostatic profiling included comparing the effects of LBNP on coagulation values in both phases of the menstrual cycle using standard coagulation tests, calibrated automated thrombogram, thrombelastometry, impedance aggregometry, and markers of thrombin formation. Results: LBNP led to coagulation activation determined in both plasma and WB samples. During both phases, coagulation was affected during LBNP, as reflected in their decreased partial thromboplastin time (PTT) and elevated coagulation factor VIII FVIII, F1 + 2, and thrombin-antithrombin (TAT) levels. Additionally, during the ML phase, greater PT [%] and shorter time to peak (ttPeak) values (implying faster maximum thrombin formation) suggest that women in the ML phase are relatively hypercoagulable compared to the early follicular phase. Conclusions: These results suggest that thrombosis occurs more during the midluteal phase, a finding with substantial medical implications.https://www.mdpi.com/2077-0383/9/10/3118coagulationmenstrual phasethrombelastometrythrombin generation
spellingShingle Nandu Goswami
Bianca Brix
Andreas Roessler
Martin Koestenberger
Gilbert Reibnegger
Gerhard Cvirn
Menstrual Phase Affects Coagulation and Hematological Parameters during Central Hypovolemia
Journal of Clinical Medicine
coagulation
menstrual phase
thrombelastometry
thrombin generation
title Menstrual Phase Affects Coagulation and Hematological Parameters during Central Hypovolemia
title_full Menstrual Phase Affects Coagulation and Hematological Parameters during Central Hypovolemia
title_fullStr Menstrual Phase Affects Coagulation and Hematological Parameters during Central Hypovolemia
title_full_unstemmed Menstrual Phase Affects Coagulation and Hematological Parameters during Central Hypovolemia
title_short Menstrual Phase Affects Coagulation and Hematological Parameters during Central Hypovolemia
title_sort menstrual phase affects coagulation and hematological parameters during central hypovolemia
topic coagulation
menstrual phase
thrombelastometry
thrombin generation
url https://www.mdpi.com/2077-0383/9/10/3118
work_keys_str_mv AT nandugoswami menstrualphaseaffectscoagulationandhematologicalparametersduringcentralhypovolemia
AT biancabrix menstrualphaseaffectscoagulationandhematologicalparametersduringcentralhypovolemia
AT andreasroessler menstrualphaseaffectscoagulationandhematologicalparametersduringcentralhypovolemia
AT martinkoestenberger menstrualphaseaffectscoagulationandhematologicalparametersduringcentralhypovolemia
AT gilbertreibnegger menstrualphaseaffectscoagulationandhematologicalparametersduringcentralhypovolemia
AT gerhardcvirn menstrualphaseaffectscoagulationandhematologicalparametersduringcentralhypovolemia